Curious how top #biotech companies speed up process development? We've got insights from 3 industry leaders on: ✔️ Top external factors influencing process development teams ✔️ Considerations for prioritizing digital initiatives ✔️ Role of technology & #datascience across process development 👉 Read the full story: https://lnkd.in/gHqbA-Zh
Benchling’s Post
More Relevant Posts
-
🎥 Excited to share my recent presentation on Blue and Red Ocean Strategy, alongside insights into Business Model Canvas, tailored specifically for the dynamic landscape of the biotech industry. #Biotech #Strategy #BusinessModelCanvas #BlueOceanStrategy #RedOceanStrategy
-
For #biotech #data teams it's often tempting to automate every process. But sometimes a less formal process may actually be better. Upgrading processes and infrastructure to be more formal and structured is an investment that doesn't always pay off. Plus it reduces flexibility that may be more important than the consistency you gain. But most importantly, it's much more difficult, if not impossible to formalize a process if adjacent components are still informal. I discussed all this in more detail in the latest post to my weekly newsletter, Scaling Biotech. https://buff.ly/4bDN1gB
-
I know we talk about automation a lot, but not all processes are ready for automation. This is a thoughtful/realistic discussion about when workflows are not ready, or when automation isn't worth it when the scale isn't there.
For #biotech #data teams it's often tempting to automate every process. But sometimes a less formal process may actually be better. Upgrading processes and infrastructure to be more formal and structured is an investment that doesn't always pay off. Plus it reduces flexibility that may be more important than the consistency you gain. But most importantly, it's much more difficult, if not impossible to formalize a process if adjacent components are still informal. I discussed all this in more detail in the latest post to my weekly newsletter, Scaling Biotech. https://buff.ly/4bDN1gB
Time for automation? It's less common than you think...
-
Biopharma Entrepreneur helping companies value assets, refine business cases for investor funding, and make evidence based decisions.
Interesting results from our poll. About half of responses show that forecasts are used to inform portfolio prioritization decisions. The other half of responses are split evenly suggesting financial planning and investment decisions are impacted by forecasts less frequently. In all cases, forecasts help leaders make important decisions. #insights #decisionmaking #biotech
-
-
The golden era of bioenhancements has begun, yet the question arises: are we steering in the right direction? Pioneering the longevity era will require educating, delivering, and developing new bioenhancement tools, building an unparalleled biotech ecosystem. Read my latest on X. https://lnkd.in/dpsGcYq7
-
-
"Our customers say wow! And our competitors say how?" That's the power of Enbio Group AG's workflow-revolutionizing technology. Hear the story straight from CEO William Kubofcik on this episode of Emphasis Tech Talks with David Clausen. We're diving into process optimization, faster sterilization, and how to gain a competitive edge. Don't miss out on these valuable insights, full episode here https://lnkd.in/eX_3vXHg! #competitoranalysis #businesstransformation #innovation #disruptivetech #techtalks
-
🚀 Exciting Times Ahead at BioTechX EU 2024! 🚀 I’m thrilled to share that Tenthpin will be participating in this incredible event on October 9th and 10th, with an insightful keynote session: "How Technology Can Save You Time and Help You Save More Lives." 💡 Our very own experts, Marta Ramponi and Bart Reijs, will dive into key areas where digital innovation is transforming life sciences, including: 🔬 Cost-Efficient R&D Strategies – Learn how advanced analytics and digital tools are enabling smarter decision-making, optimized resource allocation, and cost-effective R&D management. 💼 Streamlined Financial Operations – Discover how automation is bringing greater transparency, control, and efficiency to financial processes, from budgeting to reporting. ⚖️ Risk Mitigation and Compliance – Explore how real-time monitoring and data analytics are driving better risk management, ensuring compliance, and preventing costly project delays. If you're attending, don’t miss this opportunity to learn about the digital solutions driving impact in life sciences. Let’s connect and explore how technology can revolutionize our industry! #BiotechX #Tenthpin #Innovation #LifeSciences #DigitalTransformation #Healthcare #R&D #Automation #Compliance #FutureOfHealth
Tenthpin will be participating in the BioTechX EU event on October 9th and 10th, 2024, with a keynote session on “How Technology Can Save You Time and Help You Save More Lives.” This session will explore how technology is transforming operations and improving outcomes in Life Sciences. Tenthpin's experts Marta Ramponi and Bart Reijs will talk about key areas where digital tools are making a difference: - Cost-Efficient R&D Strategies: They will cover how technology can optimize R&D management, helping companies allocate resources better, plan projects more effectively, and cut costs. Advanced analytics are enabling quicker, smarter decisions. - Streamlined Financial Operations: The session will also focus on how digital financial tools and automation are improving transparency and control in budgeting, approvals, and reporting, leading to smoother operations and better financial management. - Risk Mitigation and Compliance: They will discuss how real-time monitoring and data analytics help manage risks, ensure compliance with regulations, and avoid costly delays in project execution. If you’re ready to drive digital impact in life sciences, let’s talk. #tenthpin #biotechx #digitaltransformations #lifesciences
-
-
Curious about what the Life Science industry has in store for 2024? 🧐 Discover more about innovation, adaptability, collaboration, sustainability development, specialist tech, and digitalisation. Explore what 2024 has to offer for you and your organisation. 🌐💡 Dive into the details of these key themes and get a glimpse into what lies ahead for 2024 with Dr. Eduard Cayón's latest article, our Rephine Chief Scientific Officer (CSO): https://bit.ly/3Gz94q8 📌 Save this post to help for your 2024 plans! #2024trends #biotech #supplychain #lifesciences #pharmaceuticalindustry
-
-
📖Get inspired: https://lnkd.in/gs6HDfey 📉 Read about the internal and external factors of an economic downturn, such as a lack of financial clarity and transparency, downturns in other markets, and overpriced market valuations. Discover how biotech must invest in improving communication skills and carefully evaluating product pipelines to sustain growth. #Biotech #EconomicOutlook #SustainableGrowth
-
-
Securing funding remains challenging for #biotech, creating flexible strategies to help stretch funding across the clinical development is something we can work out together. Explore #iconplc whitepapers on capital-related considerations
Securing funding is the first challenge. The next is stretching it across clinical development. In a practical, two-part #whitepaper series, we outline key considerations for #biotech companies to optimise their funding strategies, from competing for funds to utilising them most effectively in their asset development programs. Explore the whitepapers and learn helpful capital-related considerations: https://ow.ly/SQOv50QqgsG
-
Innovative Leadership in Life Sciences & Technology Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies
2wExcited to dive into these insights on accelerating process development in biotech! 🧬 The perspectives on external factors, digital initiatives, and the impact of technology and data science will be invaluable. Looking forward to reading more! 🚀